Apollo Therapeutics
Apollo Therapeutics
  • Home
  • The Challenge
  • Tackling Leukemia
  • Apollo in a Nutshell
  • Our Impact
  • Contact Us
  • More
    • Home
    • The Challenge
    • Tackling Leukemia
    • Apollo in a Nutshell
    • Our Impact
    • Contact Us
  • Home
  • The Challenge
  • Tackling Leukemia
  • Apollo in a Nutshell
  • Our Impact
  • Contact Us

Chronic Lymphocytic Leukemia...

...is also known as CLL. This particular form of leukemia includes a lack of two proteins including the ZAP-70 and CD-38 proteins that help lymphocytes take part in immune system defense. However, lacking these proteins causes them to rapidly ignore infection and leads to multiple other issues. There is no tumor formed by CLL, which makes conventional treatment ineffective.

CLL AND CHEMOTHERAPY - THE CHALLENGE

38% of Leukemia Diagnosed is CLL

27% of Cancer Patients Die by Chemo

38% of Leukemia Diagnosed is CLL

Chronic Lymphocytic Leukemia is common cancer; by finding a way to treat this could open gateways to eradicate the rest.

>50,000 Deaths by CLL in 2020

27% of Cancer Patients Die by Chemo

38% of Leukemia Diagnosed is CLL

This number is immense and solely based in the United States. Now, picture how many deaths from this cancer there are globally.

27% of Cancer Patients Die by Chemo

27% of Cancer Patients Die by Chemo

27% of Cancer Patients Die by Chemo

The medication that is supposed to help these individuals actually ends up hastening their deaths. This is due to lack of targeted delivery.

CHEMOTHERAPY ADVERSENESS

Side Effects May Include...

  • hair loss
  • mouth sores
  • loss of appetite
  • nausea and vomiting 
  • low blood cell count
  • risk of further infection
  • easy bruising and bleeding
  • fatigue
  • death

Copyright © 2022 Apollo Therapeutics - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept